Abbott Laboratories buy Jefferies Financial Group Inc.
Start price
16.10.25
/
50%
€110.74
Target price
16.10.26
€127.63
Performance (%)
-22.79%
Price
10.04.26
€85.50
Summary
This prediction is currently active. The price of Abbott Laboratories has decreased since the start of the prediction. Compared to the start price this results in a performance of -22.79%. This prediction currently runs until 16.10.26. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | -4.137% | -4.137% |
| iShares Core DAX® | 2.554% | -0.112% |
| iShares Nasdaq 100 | 2.742% | -0.470% |
| iShares Nikkei 225® | 6.584% | 3.221% |
| iShares S&P 500 | 1.930% | -0.519% |
Comments by Jefferies_Financial_ for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE:ABT) had its price target raised by analysts at Jefferies Financial Group Inc. from $145.00 to $149.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Jefferies_Financial_ for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€104.68
18.07.25
18.07.25
€124.73
18.07.26
18.07.26
-18.32%
10.04.26
10.04.26
